Document is current
Any future updates will be listed below
-
Authors
Hirota, Naomi https://orcid.org/0000-0003-1184-4228
Suzuki, Shinya
Arita, Takuto
Yagi, Naoharu
Otsuka, Takayuki
Kishi, Mikio
Semba, Hiroaki
Kano, Hiroto
Matsuno, Shunsuke
Kato, Yuko
Uejima, Tokuhisa
Oikawa, Yuji
Matsuhama, Minoru
Iida, Mitsuru
Inoue, Tatsuya
Yajima, Junji
Yamashita, Takeshi
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 11 January 2021
First Online: 10 February 2021
Ethics approval and consent to participate
: This study was performed in accordance with the ethical norms based on the Declaration of Helsinki (revised in 2013) and Ethical Guidelines for Medical and Health Research Involving Human Subjects (Public Notice of the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare, Japan, issued in 2017). Written informed consent was obtained from all participants. The study protocol was reviewed by the Institutional Review Board of the Cardiovascular Institute.
: Not applicable.
: Dr. Suzuki received research funding from Mitsubishi Tanabe Pharm, and Daiichi Sankyo. Dr. Yamashita has received research funds and/or lecture fees from Daiichi Sankyo, Bayer Yakuhin, Bristol-Myers Squibb, Pfizer, Nippon Boehringer Ingelheim, Eisai, Mitsubishi Tanabe Pharm, Ono Pharmaceutical, and Toa Eiyo.
